Corbevax vaccine gets WHO Emergency Use Listing authorisation

​​The company supplied 100 million doses of Corbevax to the central government which were then utilized in pan-India immunization campaigns, mainly in children aged 12-14 years, the release said. Datla said that several companies which started vaccine development or manufacture during the COVID-19 pandemic exited later due to paucity of funds or lack of success.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news